CORT Price Targets and Analyst Ratings NASDAQ:CORT
CORT Forecast. What You Should Know.
CORT Historical Ratings and Targets
About Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.